Cancer Immunotherapy Websites
Cancer Research Institute - Advancing Immunotherapy Research
The Cancer Research Institute (CRI) is a nonprofit organization dedicated exclusively to advancing immunotherapy to treat, control, and cure all cancers.
285,766
$
31,320.00
Society for Immunotherapy of Cancer (SITC)
The Society for Immunotherapy of Cancer (SITC) is a 501 (c)(3) non-profit medical professional society of influential scientists, academicians, researchers, clinicians, government representatives, and industry leaders from around the world dedicated to improving cancer patient outcomes by advancing the science and appl
Not Applicable
$
8.95
Bavarian Nordic
Bavarian Nordic is an international biotechnology company developing and manufacturing novel cancer immunotherapies and vaccines for infectious diseases.
1,454,376
$
960.00
Apogenix ǀ Immuno-oncology therapeutics for the treatment of cancer an
Apogenix develops innovative protein therapeutics for the treatment of cancer and other malignant diseases. Our lead drug candidate APG101 has demonstrated a statistically significant efficacy in a controlled phase II trial in recurrent glioblastoma.
3,446,235
$
480.00
Home: Trophogen Inc. Improving Human and Animal Health With Protein En
Trophogen Inc webpage.
2,701,914
$
480.00
Immunotherapy: The Answer to Cancer - Cancer Research Institute
Immunotherapy has the potential to change how ALL cancers are treated & cured. The Cancer Research Institute is dedicated to advancing immunotherapy research.
Not Applicable
$
8.95
PREDICINE (Chinese) - 主页
Predicine was established and the business model is to develop precision diagnostics and enable precision medicine through partnering with international pharmaceutical, biotechnology and diagnostics industries.
Not Applicable
$
8.95
GcMAF Forte | LABRMS
GcMAF Forte - THE NEW AGE OF CANCER IMMUNOTHERAPY
Not Applicable
$
8.95
GcMAF FORTE | LABRMS
GcMAF FORTE- The New Age of Non-Invasive Cancer Immunotherapy
Not Applicable
$
8.95
Epivax Oncology | Precision Medicine | United States
EpiVax Oncology, a precision cancer immunotherapy company, is developing mutanome-directed, neo-epitope personalized therapeutic vaccines. EpiVax Oncology’s therapeutic vaccines are customized and specifically designed for each patient’s tumors, leveraging advances in next generation immunology.
Not Applicable
$
8.95
